Daltry Dott, MD
Pain Medicine · Dallas, TXNPI 1962768473
Payments from drug & device makers
Across 48 payments — averaging $31.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$468
- Abbott$162
- Saluda Medical Americas, Inc.$143
- MML US, Inc.$122
- Vertex$101
- Globus Medical$91
- plus $435 from 18 others
What the payments were for
- Food & beverage$1,522100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $468 |
| Abbott | 9 | $162 |
| Saluda Medical Americas, Inc. | 1 | $143 |
| MML US, Inc. | 1 | $122 |
| Vertex | 1 | $101 |
| Globus Medical | 4 | $91 |
| Medtronic(2 entities) | 3 | $69 |
| Stryker | 2 | $54 |
| Nevro Corp. | 2 | $47 |
| Assertio Therapeutics, Inc. | 2 | $36 |
| Vertos Medical, Inc. | 1 | $32 |
| Pfizer | 2 | $25 |
| Relievant Medsystems, Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
| Sanara Medtech Inc. | 1 | $16 |
| Si-bone, Inc. | 1 | $14 |
| SPR Therapeutics, Inc | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Shionogi Inc | 1 | $13 |
| Stratus Medical, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke$143
- ReActiv8$122
- GENERAL PAIN MANAGEMENT$112
How this compares
$1,522 in reported general payments places this provider in the 30th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 268 | $3,981 |
| Pregabalin | 187 | $2,973 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 75 | $2,634 |
| Lidocaine | 33 | $2,517 |
| Duloxetine Hcl | 176 | $2,503 |
| Methocarbamol | 84 | $1,785 |
| Celecoxib | 36 | $1,006 |
| Memantine Hcl | 52 | $938 |
| Tizanidine Hcl | 24 | $400 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $354 |
| Cyclobenzaprine Hcl | 18 | $335 |
| Meloxicam | 62 | $127 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Dallas
- Muhammad ZulqarnainDallas$556K
- Amol PatwardhanDallas$177K
- Justin ThompsonDallas$45K
- Demaceo HowardDallas$39K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.